Skip to main content
Top
Published in: BMC Cancer 1/2024

Open Access 01-12-2024 | Thyroid Cancer | Research

Correlation between socioeconomic indices and epidemiological indices of thyroid cancer from 1990 to 2019 year: a global ecologic study

Authors: Zahra Maleki, Jafar Hassanzadeh, Haleh Ghaem

Published in: BMC Cancer | Issue 1/2024

Login to get access

Abstract

Background

The incidence of thyroid cancer as the most common type of endocrine gland malignancy has risen more significantly than any malignancies in recent years. Estimated new cases of thyroid cancer in the United States in 2024 were 12,500 and 31,520 for men and women, respectively, and estimated deaths were 1,180 for women and 990 for men. Indices of socio-economic have been commonly used to measure the development of countries. Therefore, this study aimed to examine the correlation between indices of socioeconomic status and epidemiological indices of thyroid cancer throughout the world. In addition, this study has compared two indices of human development and a socio-demographic index.

Method

This worldwide ecological study used data on thyroid cancer incidence, mortality, human development index (HDI), and sociodemographic index (SDI) between 1990 and 2019 from the Global Burden of Disease (GBD). We evaluated the correlation between incidence and mortality rates with socioeconomic indices by using Pearson’s correlation coefficient. Furthermore, for the first time, the generalized additive model (GAM) was employed for modeling. The statistical software R, version 4.2.2, was used to conduct all statistical analyses.

Results

The correlation between the incidence of thyroid cancer and the HDI was significant and positive (r = 0.47, p-value < 0.001). While the correlation between thyroid cancer mortality and HDI was not statistically significant (r = 0.01, p-value = 0.076). Besides, the incidence of thyroid cancer was significantly positively correlated with SDI (r = 0.48, p-value < 0.001). The multiple GAM showed that for one unit increase in HDI, the risk of thyroid cancer was increased by 2.1 times (RR = 2.1, 95%CI = 2.04 to 2.19), and for one unit increase in SDI, the risk of thyroid cancer was shown to increase by 2.2 times. (RR = 2.2, 95%CI = 2.19 to 2.35).

Conclusion

It has been evident that countries with higher incidence of thyroid cancer display higher socioeconomic indices. While, countries with higher socioeconomic indices, report lower mortality rates. However, based on the modeling results, it can be concluded that the SDI is slightly more useful in this regard. Therefore, examining the epidemiological indices of thyroid cancer by socio-economic indices can be useful to reflect a clear image of the distribution of this cancer in each country, and can be used for planning cancer prevention strategies.
Appendix
Available only for authorised users
Literature
1.
go back to reference Davies L, Welch HG. Increasing incidence of thyroid cancer in the United States, 1973–2002. JAMA. 2006;295(18):2164–7.CrossRefPubMed Davies L, Welch HG. Increasing incidence of thyroid cancer in the United States, 1973–2002. JAMA. 2006;295(18):2164–7.CrossRefPubMed
2.
go back to reference Siegel RL, Giaquinto AN, Jemal AJC. Cancer statistics, 2024. 2024. Siegel RL, Giaquinto AN, Jemal AJC. Cancer statistics, 2024. 2024.
3.
go back to reference La Vecchia C, Malvezzi M, Bosetti C, Garavello W, Bertuccio P, Levi F. Negri EJIjoc: thyroid cancer mortality and incidence: a global overview. 2015, 136(9):2187–95. La Vecchia C, Malvezzi M, Bosetti C, Garavello W, Bertuccio P, Levi F. Negri EJIjoc: thyroid cancer mortality and incidence: a global overview. 2015, 136(9):2187–95.
4.
go back to reference Tran Q-L, Davies LJCOE, Research M. Thyroid Cancer Incidence Differences between Men Women. 2023:100472. Tran Q-L, Davies LJCOE, Research M. Thyroid Cancer Incidence Differences between Men Women. 2023:100472.
5.
go back to reference Fitzmaurice C, Dicker D, Pain A, Hamavid H, Moradi-Lakeh M, MacIntyre MF, Allen C, Hansen G, Woodbrook R, Wolfe C. The global burden of cancer 2013. JAMA Oncol. 2015;1(4):505–27.CrossRefPubMed Fitzmaurice C, Dicker D, Pain A, Hamavid H, Moradi-Lakeh M, MacIntyre MF, Allen C, Hansen G, Woodbrook R, Wolfe C. The global burden of cancer 2013. JAMA Oncol. 2015;1(4):505–27.CrossRefPubMed
6.
go back to reference Salehiniya H, Pakzad R, Hassanipour S, Mohammadian M. The incidence and mortality of thyroid cancer and its relationship with HDI in the world. World Cancer Res J. 2018;5(2):1–6. Salehiniya H, Pakzad R, Hassanipour S, Mohammadian M. The incidence and mortality of thyroid cancer and its relationship with HDI in the world. World Cancer Res J. 2018;5(2):1–6.
7.
go back to reference Sipos J, Mazzaferri EL. Thyroid cancer epidemiology and prognostic variables. Clin Oncol. 2010;22(6):395–404.CrossRef Sipos J, Mazzaferri EL. Thyroid cancer epidemiology and prognostic variables. Clin Oncol. 2010;22(6):395–404.CrossRef
8.
go back to reference Bendouida A, Moulessehoul S, Harir N, Rih A, Diaf M, Belhandouze L. Epidemiology, diagnosis and treatement of thyroid cancer in Western Algeria (Sidi Bel Abbes region). J Africain Du Cancer/African J Cancer. 2015;7:213–7.CrossRef Bendouida A, Moulessehoul S, Harir N, Rih A, Diaf M, Belhandouze L. Epidemiology, diagnosis and treatement of thyroid cancer in Western Algeria (Sidi Bel Abbes region). J Africain Du Cancer/African J Cancer. 2015;7:213–7.CrossRef
9.
go back to reference Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics, 2002. Cancer J Clin. 2005;55(2):74–108.CrossRef Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics, 2002. Cancer J Clin. 2005;55(2):74–108.CrossRef
10.
go back to reference Goodarzi E, Moslem A, Feizhadad H, Jarrahi AM, Adineh HA, Sohrabivafa M, Khazaei Z. Epidemiology, incidence and mortality of thyroid cancer and their relationship with the human development index in the world: an ecology study in 2018. Adv Hum Biology. 2019;9(2):162–7.CrossRef Goodarzi E, Moslem A, Feizhadad H, Jarrahi AM, Adineh HA, Sohrabivafa M, Khazaei Z. Epidemiology, incidence and mortality of thyroid cancer and their relationship with the human development index in the world: an ecology study in 2018. Adv Hum Biology. 2019;9(2):162–7.CrossRef
13.
go back to reference Bray F, Jemal A, Grey N, Ferlay J, Forman D. Global cancer transitions according to the Human Development Index (2008–2030): a population-based study. Lancet Oncol. 2012;13(8):790–801.CrossRefPubMed Bray F, Jemal A, Grey N, Ferlay J, Forman D. Global cancer transitions according to the Human Development Index (2008–2030): a population-based study. Lancet Oncol. 2012;13(8):790–801.CrossRefPubMed
14.
go back to reference Herrera-Serna BY, Lara-Carrillo E, Toral-Rizo VH, do Amaral RC, Aguilera-Eguía RA. Relationship between the human development index and its components with oral cancer in Latin America. J Epidemiol Global Health. 2019;9(4):223.CrossRef Herrera-Serna BY, Lara-Carrillo E, Toral-Rizo VH, do Amaral RC, Aguilera-Eguía RA. Relationship between the human development index and its components with oral cancer in Latin America. J Epidemiol Global Health. 2019;9(4):223.CrossRef
15.
go back to reference Mahdavifar N, Ghoncheh M, Mohammadian-Hafshejani A, Khosravi B, Salehiniya H. Epidemiology and inequality in the incidence and mortality of nasopharynx cancer in Asia. Osong Public Health Res Perspect. 2016;7(6):360–72.CrossRefPubMedPubMedCentral Mahdavifar N, Ghoncheh M, Mohammadian-Hafshejani A, Khosravi B, Salehiniya H. Epidemiology and inequality in the incidence and mortality of nasopharynx cancer in Asia. Osong Public Health Res Perspect. 2016;7(6):360–72.CrossRefPubMedPubMedCentral
16.
go back to reference Rafiemanesh H, Mehtarpour M, Khani F, Hesami SM, Shamlou R, Towhidi F, Salehiniya H, Makhsosi BR, Moini A. Epidemiology, incidence and mortality of lung cancer and their relationship with the development index in the world. J Thorac Disease. 2016;8(6):1094.CrossRef Rafiemanesh H, Mehtarpour M, Khani F, Hesami SM, Shamlou R, Towhidi F, Salehiniya H, Makhsosi BR, Moini A. Epidemiology, incidence and mortality of lung cancer and their relationship with the development index in the world. J Thorac Disease. 2016;8(6):1094.CrossRef
17.
go back to reference Khazaei Z, Goodarzi E, Borhaninejad V, Iranmanesh F, Mirshekarpour H, Mirzaei B, Naemi H, Bechashk SM, Darvishi I, Ershad Sarabi RJBPH. The association between incidence and mortality of brain cancer and human development index (HDI): an ecological study. 2020, 20(1):1–7. Khazaei Z, Goodarzi E, Borhaninejad V, Iranmanesh F, Mirshekarpour H, Mirzaei B, Naemi H, Bechashk SM, Darvishi I, Ershad Sarabi RJBPH. The association between incidence and mortality of brain cancer and human development index (HDI): an ecological study. 2020, 20(1):1–7.
18.
go back to reference Khazaei Z, Namayandeh SM, Beiranvand R, Naemi H, Bechashk SM. Goodarzi EJJopm, hygiene: Worldwide incidence and mortality of ovarian cancer and Human Development Index (HDI): GLOBOCAN sources and methods 2018. 2021, 62(1):E174. Khazaei Z, Namayandeh SM, Beiranvand R, Naemi H, Bechashk SM. Goodarzi EJJopm, hygiene: Worldwide incidence and mortality of ovarian cancer and Human Development Index (HDI): GLOBOCAN sources and methods 2018. 2021, 62(1):E174.
19.
go back to reference Ferlay J, Soerjomataram I, Ervik M, Dikshit R, Eser S, Mathers C, Rebelo M, Parkin D, Forman D, Bray F. GLOBOCAN 2012 v1. 0, Cancer incidence and mortality worldwide: IARC CancerBase No. 11. 2013. In.; 2014. Ferlay J, Soerjomataram I, Ervik M, Dikshit R, Eser S, Mathers C, Rebelo M, Parkin D, Forman D, Bray F. GLOBOCAN 2012 v1. 0, Cancer incidence and mortality worldwide: IARC CancerBase No. 11. 2013. In.; 2014.
20.
go back to reference Pellegriti G, Frasca F, Regalbuto C, Squatrito S, Vigneri R. Worldwide increasing incidence of thyroid cancer: update on epidemiology and risk factors. Journal of cancer epidemiology 2013, 2013. Pellegriti G, Frasca F, Regalbuto C, Squatrito S, Vigneri R. Worldwide increasing incidence of thyroid cancer: update on epidemiology and risk factors. Journal of cancer epidemiology 2013, 2013.
21.
go back to reference McBride GJNcrH-. A proposal for strength-of-agreement criteria for Lin’s concordance correlation coefficient. 2005, 45:307–10. McBride GJNcrH-. A proposal for strength-of-agreement criteria for Lin’s concordance correlation coefficient. 2005, 45:307–10.
22.
go back to reference Dehghan A, Khanjani N, Bahrampour A, Goudarzi G, Yunesian MJB. The relation between air pollution and respiratory deaths in Tehran, Iran-using generalized additive models. 2018, 18(1):1–9. Dehghan A, Khanjani N, Bahrampour A, Goudarzi G, Yunesian MJB. The relation between air pollution and respiratory deaths in Tehran, Iran-using generalized additive models. 2018, 18(1):1–9.
23.
go back to reference Ethan CJ, Mokoena KK, Yu Y, Shale K, Fan Y, Rong J, Liu FJES, Research P. Association between PM 2.5 and mortality of stomach and colorectal cancer in Xi’an: a time-series study. 2020, 27:22353–63. Ethan CJ, Mokoena KK, Yu Y, Shale K, Fan Y, Rong J, Liu FJES, Research P. Association between PM 2.5 and mortality of stomach and colorectal cancer in Xi’an: a time-series study. 2020, 27:22353–63.
24.
go back to reference Maleki Z, Hassanzadeh J, Méndez-Arriaga F, Ghaem HJES, Research P. Environmental factors and incidence of thyroid cancer in the world (1990–2019): an ecological study. 2023, 30(44):100072–7. Maleki Z, Hassanzadeh J, Méndez-Arriaga F, Ghaem HJES, Research P. Environmental factors and incidence of thyroid cancer in the world (1990–2019): an ecological study. 2023, 30(44):100072–7.
25.
go back to reference Ghoncheh M, Mirzaei M, Salehiniya H. Incidence and mortality of breast Cancer and their relationship with the Human Development Index (HDI) in the World in 2012. Asian Pac J Cancer Prev. 2016;16(18):8439–43.CrossRef Ghoncheh M, Mirzaei M, Salehiniya H. Incidence and mortality of breast Cancer and their relationship with the Human Development Index (HDI) in the World in 2012. Asian Pac J Cancer Prev. 2016;16(18):8439–43.CrossRef
26.
go back to reference Udelsman R, Zhang YJT. The epidemic of thyroid cancer in the United States: the role of endocrinologists and ultrasounds. 2014, 24(3):472–9. Udelsman R, Zhang YJT. The epidemic of thyroid cancer in the United States: the role of endocrinologists and ultrasounds. 2014, 24(3):472–9.
27.
go back to reference Vaccarella S, Dal Maso L, Laversanne M, Bray F, Plummer M, Franceschi SJT. The impact of diagnostic changes on the rise in thyroid cancer incidence: a population-based study in selected high-resource countries. 2015, 25(10):1127–36. Vaccarella S, Dal Maso L, Laversanne M, Bray F, Plummer M, Franceschi SJT. The impact of diagnostic changes on the rise in thyroid cancer incidence: a population-based study in selected high-resource countries. 2015, 25(10):1127–36.
28.
go back to reference Hall SF, Irish J, Groome P, Griffiths RJCM. Access, excess, and overdiagnosis: the case for thyroid cancer. 2014, 3(1):154–61. Hall SF, Irish J, Groome P, Griffiths RJCM. Access, excess, and overdiagnosis: the case for thyroid cancer. 2014, 3(1):154–61.
29.
go back to reference Zevallos JP, Hartman CM, Kramer JR, Sturgis EM, Chiao EYJC. Increased thyroid cancer incidence corresponds to increased use of thyroid ultrasound and fine-needle aspiration: a study of the Veterans affairs health care system. 2015, 121(5):741–6. Zevallos JP, Hartman CM, Kramer JR, Sturgis EM, Chiao EYJC. Increased thyroid cancer incidence corresponds to increased use of thyroid ultrasound and fine-needle aspiration: a study of the Veterans affairs health care system. 2015, 121(5):741–6.
30.
go back to reference Liu H, Wang X, Yang R, Zeng W, Peng D, Li J, Wang HJB. Recent development of nuclear molecular imaging in thyroid cancer. 2018, 2018. Liu H, Wang X, Yang R, Zeng W, Peng D, Li J, Wang HJB. Recent development of nuclear molecular imaging in thyroid cancer. 2018, 2018.
31.
go back to reference Palot Manzil FF, Kaur H. Radioactive Iodine for Thyroid Malignancies. In: StatPearls edn. Treasure Island (FL) relationships with ineligible companies. Disclosure: Harleen Kaur declares no relevant financial relationships with ineligible companies.: StatPearls Publishing Copyright © 2024, StatPearls Publishing LLC.; 2024. Palot Manzil FF, Kaur H. Radioactive Iodine for Thyroid Malignancies. In: StatPearls edn. Treasure Island (FL) relationships with ineligible companies. Disclosure: Harleen Kaur declares no relevant financial relationships with ineligible companies.: StatPearls Publishing Copyright © 2024, StatPearls Publishing LLC.; 2024.
32.
go back to reference Li N, Du XL, Reitzel LR, Xu L, Sturgis EMJT. Impact of enhanced detection on the increase in thyroid cancer incidence in the United States: review of incidence trends by socioeconomic status within the surveillance, epidemiology, and end results registry, 1980–2008. 2013, 23(1):103–10. Li N, Du XL, Reitzel LR, Xu L, Sturgis EMJT. Impact of enhanced detection on the increase in thyroid cancer incidence in the United States: review of incidence trends by socioeconomic status within the surveillance, epidemiology, and end results registry, 1980–2008. 2013, 23(1):103–10.
33.
go back to reference Yang L, Shen W, Sakamoto N. Population-based study evaluating and predicting the probability of death resulting from thyroid cancer and other causes among patients with thyroid cancer. J Clin Oncol. 2013;31(4):468–74.CrossRefPubMed Yang L, Shen W, Sakamoto N. Population-based study evaluating and predicting the probability of death resulting from thyroid cancer and other causes among patients with thyroid cancer. J Clin Oncol. 2013;31(4):468–74.CrossRefPubMed
34.
go back to reference Deng Y, Li H, Wang M, Li N, Tian T, Wu Y, Xu P, Yang S, Zhai Z, Zhou L. Global burden of thyroid cancer from 1990 to 2017. JAMA Netw open. 2020;3(6):e208759–208759.CrossRefPubMedPubMedCentral Deng Y, Li H, Wang M, Li N, Tian T, Wu Y, Xu P, Yang S, Zhai Z, Zhou L. Global burden of thyroid cancer from 1990 to 2017. JAMA Netw open. 2020;3(6):e208759–208759.CrossRefPubMedPubMedCentral
35.
go back to reference Bao WQ, Zi H, Yuan QQ, Li LY, Deng T. Global burden of thyroid cancer and its attributable risk factors in 204 countries and territories from 1990 to 2019. Thorac Cancer. 2021;12(18):2494–503.CrossRefPubMedPubMedCentral Bao WQ, Zi H, Yuan QQ, Li LY, Deng T. Global burden of thyroid cancer and its attributable risk factors in 204 countries and territories from 1990 to 2019. Thorac Cancer. 2021;12(18):2494–503.CrossRefPubMedPubMedCentral
36.
go back to reference Azadnajafabad S, Saeedi Moghaddam S, Mohammadi E, Rezaei N, Ghasemi E, Fattahi N, Aminorroaya A, Azadnajafabad R, Aryannejad A, Rezaei N. Global, regional, and national burden and quality of care index (QCI) of thyroid cancer: a systematic analysis of the global burden of Disease Study 1990–2017. Cancer Med. 2021;10(7):2496–508.CrossRefPubMedPubMedCentral Azadnajafabad S, Saeedi Moghaddam S, Mohammadi E, Rezaei N, Ghasemi E, Fattahi N, Aminorroaya A, Azadnajafabad R, Aryannejad A, Rezaei N. Global, regional, and national burden and quality of care index (QCI) of thyroid cancer: a systematic analysis of the global burden of Disease Study 1990–2017. Cancer Med. 2021;10(7):2496–508.CrossRefPubMedPubMedCentral
37.
go back to reference Zevallos JP, Xu L, Yiu YJT. The impact of socioeconomic status on the use of adjuvant radioactive iodine for papillary thyroid cancer. 2014, 24(4):758–63. Zevallos JP, Xu L, Yiu YJT. The impact of socioeconomic status on the use of adjuvant radioactive iodine for papillary thyroid cancer. 2014, 24(4):758–63.
38.
go back to reference Jabin Z, Kwon SY, Bom H-S, Lin Y, Yang K, Inaki A, Dewi AR, Al-Ibraheem AN, Al Balooshi B, San Luis TOJNMC Jr. Clinico-social factors to choose radioactive iodine dose in differentiated thyroid cancer patients: an Asian survey. 2018, 39(4):283–9. Jabin Z, Kwon SY, Bom H-S, Lin Y, Yang K, Inaki A, Dewi AR, Al-Ibraheem AN, Al Balooshi B, San Luis TOJNMC Jr. Clinico-social factors to choose radioactive iodine dose in differentiated thyroid cancer patients: an Asian survey. 2018, 39(4):283–9.
39.
go back to reference Al-Ibraheem A, Al-Rasheed U, Mashhadani N, Abdlkadir AS, Al-Adhami DA, Ruzzeh S, Istatieh F, Mansour A, Hamdan B, Kheetan RJC. Long-term survival analysis and prognostic factors of arabic patients with differentiated thyroid carcinoma: a 20-Year observational study at the King Hussein Cancer Center (KHCC) Involving 528 patients. 2023, 15(16):4102. Al-Ibraheem A, Al-Rasheed U, Mashhadani N, Abdlkadir AS, Al-Adhami DA, Ruzzeh S, Istatieh F, Mansour A, Hamdan B, Kheetan RJC. Long-term survival analysis and prognostic factors of arabic patients with differentiated thyroid carcinoma: a 20-Year observational study at the King Hussein Cancer Center (KHCC) Involving 528 patients. 2023, 15(16):4102.
40.
go back to reference Harari A, Li N, Yeh MWJTJCE. Metabolism: racial and socioeconomic disparities in presentation and outcomes of well-differentiated thyroid cancer. 2014, 99(1):133–41. Harari A, Li N, Yeh MWJTJCE. Metabolism: racial and socioeconomic disparities in presentation and outcomes of well-differentiated thyroid cancer. 2014, 99(1):133–41.
41.
go back to reference Al-Ibraheem A, Al-Shammaa M, Abdlkadir AS, Istatieh F, Al-Rasheed U, Pascual T, Rihani R, Halalsheh H, Ismael T, Khalaf AJL. Survival Trends in Pediatric Differentiated Thyroid Cancer: A Middle Eastern Perspective. 2024, 14(1):158. Al-Ibraheem A, Al-Shammaa M, Abdlkadir AS, Istatieh F, Al-Rasheed U, Pascual T, Rihani R, Halalsheh H, Ismael T, Khalaf AJL. Survival Trends in Pediatric Differentiated Thyroid Cancer: A Middle Eastern Perspective. 2024, 14(1):158.
Metadata
Title
Correlation between socioeconomic indices and epidemiological indices of thyroid cancer from 1990 to 2019 year: a global ecologic study
Authors
Zahra Maleki
Jafar Hassanzadeh
Haleh Ghaem
Publication date
01-12-2024
Publisher
BioMed Central
Published in
BMC Cancer / Issue 1/2024
Electronic ISSN: 1471-2407
DOI
https://doi.org/10.1186/s12885-024-12176-y

Other articles of this Issue 1/2024

BMC Cancer 1/2024 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine